Drug research turns to artificial intelligence in COVID-19 fight

By Tyler Orton / Business in Vancouver
Tech company locks down government funding to repurpose drugs for virus treatment

Variational AI Inc.’s bread and butter rests in novel drug discovery, specifically using artificial intelligence (AI) to compress the years-long preclinical process to perhaps a single year. But in the midst of a pandemic, even a year might be too long to find a treatment for COVID-19, according to CEO Handol Kim.…

• Whistler News

May 10, 2020

Comments are closed.